vs
Side-by-side financial comparison of FIRSTSUN CAPITAL BANCORP (FSUN) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $110.0M, roughly 1.9× FIRSTSUN CAPITAL BANCORP). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs 1.1%, a 18.5% gap on every dollar of revenue. Over the past eight quarters, FIRSTSUN CAPITAL BANCORP's revenue compounded faster (6.9% CAGR vs 0.8%).
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
FSUN vs VREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $110.0M | $209.6M |
| Net Profit | $21.6M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | — | 7.3% |
| Net Margin | 19.6% | 1.1% |
| Revenue YoY | — | 4.9% |
| Net Profit YoY | -8.4% | 866.7% |
| EPS (diluted) | $0.76 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.0M | $209.6M | ||
| Q4 25 | $110.2M | $228.9M | ||
| Q3 25 | $107.3M | $203.0M | ||
| Q2 25 | $105.6M | $212.9M | ||
| Q1 25 | $96.2M | $199.8M | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $98.2M | $205.7M | ||
| Q2 24 | $96.2M | $209.1M |
| Q1 26 | $21.6M | $2.3M | ||
| Q4 25 | $24.8M | $12.2M | ||
| Q3 25 | $23.2M | $-89.1M | ||
| Q2 25 | $26.4M | $6.9M | ||
| Q1 25 | $23.6M | $-300.0K | ||
| Q4 24 | $16.4M | — | ||
| Q3 24 | $22.4M | $-51.1M | ||
| Q2 24 | $24.6M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 29.0% | 8.6% | ||
| Q3 25 | 26.4% | -39.8% | ||
| Q2 25 | 31.2% | 10.4% | ||
| Q1 25 | 30.9% | 5.6% | ||
| Q4 24 | 20.4% | — | ||
| Q3 24 | 29.1% | 5.3% | ||
| Q2 24 | 32.3% | 4.4% |
| Q1 26 | 19.6% | 1.1% | ||
| Q4 25 | 22.5% | 5.3% | ||
| Q3 25 | 21.6% | -43.9% | ||
| Q2 25 | 25.0% | 3.2% | ||
| Q1 25 | 24.5% | -0.2% | ||
| Q4 24 | 16.6% | — | ||
| Q3 24 | 22.8% | -24.8% | ||
| Q2 24 | 25.5% | 0.7% |
| Q1 26 | $0.76 | $0.05 | ||
| Q4 25 | $0.89 | $0.29 | ||
| Q3 25 | $0.82 | $-2.15 | ||
| Q2 25 | $0.93 | $0.17 | ||
| Q1 25 | $0.83 | $-0.01 | ||
| Q4 24 | $0.57 | — | ||
| Q3 24 | $0.79 | $-1.25 | ||
| Q2 24 | $0.88 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $413.7M | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $1.2B | $476.9M |
| Total Assets | $8.6B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $413.7M | $125.6M | ||
| Q4 25 | $652.6M | $155.1M | ||
| Q3 25 | $659.9M | $152.6M | ||
| Q2 25 | $785.1M | $223.0M | ||
| Q1 25 | $621.4M | $212.6M | ||
| Q4 24 | $615.9M | — | ||
| Q3 24 | $573.7M | $200.5M | ||
| Q2 24 | $535.8M | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | $1.2B | $476.9M | ||
| Q4 25 | $1.2B | $472.6M | ||
| Q3 25 | $1.1B | $455.3M | ||
| Q2 25 | $1.1B | $549.7M | ||
| Q1 25 | $1.1B | $540.2M | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | $529.1M | ||
| Q2 24 | $996.6M | $581.2M |
| Q1 26 | $8.6B | $1.1B | ||
| Q4 25 | $8.5B | $1.1B | ||
| Q3 25 | $8.5B | $1.1B | ||
| Q2 25 | $8.4B | $1.4B | ||
| Q1 25 | $8.2B | $1.3B | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $8.1B | $1.2B | ||
| Q2 24 | $8.0B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-16.1M |
| Free Cash FlowOCF − Capex | — | $-26.8M |
| FCF MarginFCF / Revenue | — | -12.8% |
| Capex IntensityCapex / Revenue | — | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $111.5M | $7.9M | ||
| Q3 25 | $49.4M | $7.7M | ||
| Q2 25 | $15.0M | $16.6M | ||
| Q1 25 | $26.4M | $9.5M | ||
| Q4 24 | $101.1M | — | ||
| Q3 24 | $48.1M | $25.9M | ||
| Q2 24 | $20.9M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $104.0M | $2.3M | ||
| Q3 25 | $47.6M | $1.4M | ||
| Q2 25 | $13.0M | $9.8M | ||
| Q1 25 | $24.3M | $5.3M | ||
| Q4 24 | $95.7M | — | ||
| Q3 24 | $47.1M | $19.9M | ||
| Q2 24 | $19.9M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | 94.3% | 1.0% | ||
| Q3 25 | 44.4% | 0.7% | ||
| Q2 25 | 12.3% | 4.6% | ||
| Q1 25 | 25.3% | 2.7% | ||
| Q4 24 | 97.0% | — | ||
| Q3 24 | 47.9% | 9.7% | ||
| Q2 24 | 20.6% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 6.8% | 2.4% | ||
| Q3 25 | 1.6% | 3.1% | ||
| Q2 25 | 1.9% | 3.2% | ||
| Q1 25 | 2.1% | 2.1% | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 1.1% | 2.9% | ||
| Q2 24 | 1.1% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | 4.49× | 0.65× | ||
| Q3 25 | 2.13× | — | ||
| Q2 25 | 0.57× | 2.41× | ||
| Q1 25 | 1.12× | — | ||
| Q4 24 | 6.18× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | 0.85× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
